Former Apple CEO: This Is Why I Am Making a Huge Bet on Healthcare
Former Apple CEO John Sculley has made various bets since he left the tech giants years ago. One more recent bet is on healthcare via digitally-minded PBM RxAdvance.
Yes, former Apple AAPL CEO John Sculley is keeping active.
Actually, he is somewhat of a serial entrepreneur.
Sculley knows a thing or two about the healthcare industry as well as tech. He is an investor and chief marketing officer at upstart pharmacy benefit manager RxAdvane, which does battle with heavyweights Express Scripts (ESRX) and CVS Health (CVS) . "I think RXAdvance is the most interesting company I have worked at since Apple -- we are disrupting the most vulnerable and expensive area of the market." Sculley said he expects RxAdvance to boast $2 billion in contracted revenue by 2018 and $10 billion by 2020.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.
Email
Email sent
Thank you, your email to has been sent successfully.
